Recurrent granuloma annulare during treatment with daclizumab

Multiple Sclerosis

Volumn 15, Issue 4, 2009, Pages 527-528

  Mehta, L R ^a   Rose, J W ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; DACLIZUMAB; PREDNISONE;

ADULT; CASE REPORT; DRUG ERUPTION; DRUG RESPONSE; EOSINOPHIL; FEMALE; GRANULOMA ANNULARE; HUMAN; HUMAN TISSUE; LETTER; MULTIPLE SCLEROSIS; PERIODIC ACID SCHIFF STAIN; RECURRENT DISEASE; RELAPSE; REMISSION; SKIN BIOPSY; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; GRANULOMA ANNULARE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE;

EID: 63449129990     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508101324     Document Type: Letter

References (7)

1. Rose, JW, Watt, HE, White, AT, Carlson, NG. Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol 2004; 56: 864-867.
2. Smith, MD, Downie, JB, DiCostanzo, D. Granuloma annulare. Int J Dermatol 1997; 36: 326-333.
3. Umbert, P, Winkelmann, RK. Histologic, ultrastructural and histochemical studies of granuloma annulare. Arch Dermatol 1977; 113: 1681-1686.
4. Buechner, SA, Winkelmann, RK, Banks, PM. Identification of T-cell subpopulations in granuloma annulare. Arch Dermatol 1983; 119: 125-128.
5. Modlin, RL, Horwitz, DA, Jordan, RR, Gebhard, JF, Taylor, CR, Rea, TH. Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare. Pediatr Dermatol 1984; 2: 26-32.
6. Mempel, M, Musette, P, Flageul, B, et al. T-cell receptor repertoire and cytokine pattern in granuloma annulare: Defining a particular type of cutaneous granulomatous inflammation. J Invest Dermatol 2002; 118: 957-966.
7. Serarslan, G, Okuyucu, EE, Melek, IM, Hakverdi, S, Duman, T. Widerspread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis. Mult Scler 2008; 14: 259-261.